Overview

A Study to Evaluate the Pharmacokinetics and Safety of Fezolinetant in Healthy Chinese Female Subjects

Status:
Completed
Trial end date:
2021-05-21
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the pharmacokinetics and safety of fezolinetant after single-dose and multiple dose administration in healthy Chinese female participants.
Phase:
Phase 1
Details
Lead Sponsor:
Astellas Pharma China, Inc.